ABBV-932 to Assess Adverse Events and Change for Bipolarity
This study is completed in the United States and in Japan. It is testing ABBV-932 to Assess Adverse Events and Change for Bipolarity.
Multiple locations, including Dothan
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States and in Japan. It is testing ABBV-932 to Assess Adverse Events and Change for Bipolarity.
Multiple locations, including DothanThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Washington D.C.This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little RockThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including WorcesterThis summary needs review. Please check the official study record and contact the research team for details.
In Fort LauderdaleThis study was terminated. It is testing preladenant for schizophrenia.
Location not clearly listedThis summary needs review. Please check the official study record and contact the research team for details.
In PoitiersThis summary needs review. Please check the official study record and contact the research team for details.
In North MiamiThis summary needs review. Please check the official study record and contact the research team for details.
In LyonThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including CréteilThis summary needs review. Please check the official study record and contact the research team for details.
In IrvingThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including BuckhannonHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.